title: Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition.
abstract: The discovery of translocations that involve one of the genes of the ETS family (ERG, ETV1, ETV4 and ETV5) has been a major advance in understanding the molecular basis of prostate cancer (PC). Each one of these translocations results in deregulated expression of one of the ETS proteins. Here, we focus on the mechanism whereby overexpression of the ETV4 gene mediates oncogenesis in the prostate. By siRNA technology, we show that ETV4 inhibition in the PC3 cancer cell line reduces not only cell mobility and anchorage-independent growth, but also cell proliferation, cell cycle progression and tumor growth in a xenograft model. Conversely, ETV4 overexpression in the nonmalignant human prostate cell line (RWPE) increases anchorage-independent growth, cell mobility and cell proliferation, which is probably mediated by downregulation of p21, producing accelerated progression through the cell cycle. ETV4 overexpression is associated with changes in the pattern of E-cadherin and N-cadherin expression; the cells also become spindle-shaped, and these changes are characteristic of the so-called epithelial to mesenchymal transition (EMT). In RWPE cells overexpressing ETV4 EMT results from a marked increase in EMT-specific transcription factors such as TWIST1, SLUG1, ZEB1 and ZEB2. Thus, whereas ETV4 shares with the other ETS proteins (ERG, ETV5 and ETV1) a major role in invasiveness and cell migration, it emerges as unique in that it increases at the same time also the rate of proliferation of PC cells. Considering the wide spectrum in the clinical course of patients with PC, it may be highly relevant that ETV4 is capable of inducing most and perhaps all of the features that make a tumor aggressive.
authors.affiliation: Cancer Genetics and Gene Transfer Laboratory, Core Research Laboratory, Istituto Toscano Tumori, AOUC, Florence, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Pellecchia
authors.forename: C
authors.initials: C
authors.lastname: Pescucci
authors.forename: E
authors.initials: E
authors.lastname: De Lorenzo
authors.forename: C
authors.initials: C
authors.lastname: Luceri
authors.forename: N
authors.initials: N
authors.lastname: Passaro
authors.forename: M
authors.initials: M
authors.lastname: Sica
authors.forename: R
authors.initials: R
authors.lastname: Notaro
authors.forename: M
authors.initials: M
authors.lastname: De Angioletti
references.citation: J Clin Invest. 2009 Jun;119(6):1420-8
references.pmid: 19487818
references.citation: Cell. 2010 Apr 2;141(1):52-67
references.pmid: 20371345
references.citation: Cancer Res. 1991 Sep 1;51(17):4716-20
references.pmid: 1873816
references.citation: Adv Exp Med Biol. 2000;480:107-16
references.pmid: 10959416
references.citation: Oral Oncol. 1997 Nov;33(6):426-30
references.pmid: 9509127
references.citation: Cancer Res. 2006 Nov 1;66(21):10242-6
references.pmid: 17079440
references.citation: Cell. 2009 Nov 25;139(5):871-90
references.pmid: 19945376
references.citation: Cell. 1993 Nov 19;75(4):817-25
references.pmid: 8242752
references.citation: J Cell Sci. 2009 Apr 1;122(Pt 7):1014-24
references.pmid: 19295128
references.citation: Cancer Res. 2006 Aug 15;66(16):8007-16
references.pmid: 16912176
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3260-5
references.pmid: 10737792
references.citation: Cancer Res. 1977 Nov;37(11):4049-58
references.pmid: 908039
references.citation: J Pathol. 2011 May;224(1):78-89
references.pmid: 21404275
references.citation: Nat Med. 2000 Feb;6(2):189-95
references.pmid: 10655108
references.citation: Biochem Biophys Res Commun. 2007 Jun 22;358(1):53-8
references.pmid: 17467662
references.citation: Nat Rev Cancer. 2009 Mar;9(3):153-66
references.pmid: 19238148
references.citation: Genes Chromosomes Cancer. 2012 Mar;51(3):240-9
references.pmid: 22081504
references.citation: Genes Cancer. 2011 Jan 1;1(10):1044-1052
references.pmid: 21373373
references.citation: Nat Genet. 2004 Apr;36(4):331-4
references.pmid: 15054488
references.citation: Nat Genet. 2009 May;41(5):619-24
references.pmid: 19396168
references.citation: Nat Rev Urol. 2011 Jun 21;8(8):428-39
references.pmid: 21691304
references.citation: J Virol. 2003 Aug;77(16):8957-61
references.pmid: 12885912
references.citation: Cancer Res. 2009 May 1;69(9):3819-27
references.pmid: 19383905
references.citation: Nat Genet. 2009 May;41(5):524-6
references.pmid: 19396167
references.citation: Oncogene. 1996 Jan 18;12(2):221-7
references.pmid: 8570199
references.citation: Prostate. 2011 Sep;71(12):1332-43
references.pmid: 21321977
references.citation: Oncogene. 1999 Mar 4;18(9):1771-6
references.pmid: 10208438
references.citation: Nat Med. 2010 Mar;16(3):286-94
references.pmid: 20154697
references.citation: Semin Cancer Biol. 2010 Jun;20(3):161-8
references.pmid: 20470890
references.citation: Nat Rev Mol Cell Biol. 2006 Feb;7(2):131-42
references.pmid: 16493418
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2105-10
references.pmid: 18245377
references.citation: Cancer Res. 2006 Apr 1;66(7):3396-400
references.pmid: 16585160
references.citation: Cancer Res. 2010 Sep 1;70(17):6735-45
references.pmid: 20713528
references.citation: FEBS Lett. 2004 Feb 27;560(1-3):183-91
references.pmid: 14988020
references.citation: J Cell Physiol. 2007 Nov;213(2):374-83
references.pmid: 17680632
references.citation: Cancer Res. 2005 Jul 15;65(14):5991-5; discussion 5995
references.pmid: 16024595
references.citation: Cancer Res. 2008 Sep 15;68(18):7629-37
references.pmid: 18794152
references.citation: Am J Pathol. 2009 May;174(5):1588-93
references.pmid: 19342369
references.citation: Dev Cell. 2008 Jun;14(6):818-29
references.pmid: 18539112
references.citation: Oncogene. 1995 Apr 6;10(7):1461-3
references.pmid: 7731700
references.citation: J Biol Chem. 2004 Mar 19;279(12):11281-92
references.pmid: 14662758
references.citation: PLoS One. 2011;6(7):e21650
references.pmid: 21747944
references.citation: Int J Dev Biol. 2004;48(5-6):365-75
references.pmid: 15349812
references.citation: Int J Cancer. 2001 Sep;93(6):786-91
references.pmid: 11519038
references.citation: Mol Cell Biol. 2001 Feb;21(4):1370-83
references.pmid: 11158322
references.citation: Nature. 2007 Aug 2;448(7153):595-9
references.pmid: 17671502
references.citation: Cell. 2004 Jun 25;117(7):927-39
references.pmid: 15210113
references.citation: Mol Carcinog. 2006 Sep;45(9):667-75
references.pmid: 16652376
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2485-90
references.pmid: 20080667
references.citation: Neoplasia. 2008 Feb;10(2):177-88
references.pmid: 18283340
references.citation: J Pathol. 2003 Aug;200(5):568-76
references.pmid: 12898592
references.citation: Nat Cell Biol. 2008 May;10(5):593-601
references.pmid: 18376396
references.citation: Oncogene. 1997 Sep 25;15(13):1513-25
references.pmid: 9380403
references.citation: Nat Biotechnol. 1997 Sep;15(9):871-5
references.pmid: 9306402
references.citation: Br J Cancer. 1985 Mar;51(3):419-23
references.pmid: 3970818
references.citation: Neoplasia. 2009 Nov;11(11):1208-15
references.pmid: 19881956
references.citation: Science. 2005 Oct 28;310(5748):644-8
references.pmid: 16254181
references.citation: Nat Rev Cancer. 2009 Apr;9(4):265-73
references.pmid: 19262571
references.citation: Cancer Cell. 2005 Sep;8(3):197-209
references.pmid: 16169465
references.citation: Cancer Res. 2008 May 1;68(9):3094-8
references.pmid: 18451133
references.citation: Biochem Biophys Res Commun. 2006 Jun 23;345(1):216-21
references.pmid: 16678123
references.citation: Mol Cancer Res. 2011 Aug;9(8):997-1007
references.pmid: 21665936
references.citation: Cancer Res. 2006 Aug 15;66(16):7870-9
references.pmid: 16912160
references.citation: J Clin Oncol. 2011 Sep 20;29(27):3659-68
references.pmid: 21859993
references.citation: Nat Rev Cancer. 2009 Jun;9(6):400-14
references.pmid: 19440234
references.citation: Nat Rev Cancer. 2009 Jun;9(6):441-4
references.pmid: 19461668